Citrix Takeover Chatter Intensifies
The core business faces meaningful long-term challenges, but the business makes sense in the hands of private equity investors that can milk the legacy business for cash.
Citrix (CTXS) shares spiked 7% on Monday, March 13, as reports circulated that the company is exploring a sale. The company has been the target of several changes over the last two years, headlined by activist Elliott Management pushing for board seats, leadership changes, the spin-off of the GoTo family of products, and potentially an outright sale of the core Citrix business. On the latter point, it appears those talks have been renewed, with news outlet Reuters reporting private equity firm Thoma Bravo is among several PE shops looking at a potential Citrix acquisition. Bloomberg is reporting that Citrix has retained Goldman Sachs to explore a sale. We think this outcome would be a best-case scenario for Citrix shareholders. We are maintaining our narrow moat rating and $64 fair value estimate (as no deal has come to fruition at this stage), and we think the stock looks meaningfully overvalued.
Rumors of a Citrix takeover first surfaced in 2015 when Elliott Management took an activist stake in the company, though buyers for Citrix’s core business failed to materialize. We think the core Citrix business faces meaningful long-term challenges, as desktop virtualization has had limited market penetration and the firm’s NetScaler business faces stiff competition from F5 Networks, among others. Still, the economics of desktop virtualization contracts remain beneficial, and we think the business makes sense in the hands of private equity investors that can milk the legacy business for cash. As a standalone public company, however, we think Citrix will struggle to grow its top-line, and the firm has largely extracted as much margin expansion as we would reasonably expect over the last few years (non-GAAP operating margins expanded 900 basis points in the last two years to 30.8% in fiscal 2016).
Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.
Rodney Nelson does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.